Order Article Reprints

Schneider M, Schäfer N, Bode C, Eichhorn L, Giordano FA, Güresir E, Heimann M, Ko Y-D, Landsberg J, Lehmann F, et al. The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival. Journal of Clinical Medicine. 2021; 10(17):4013. https://doi.org/10.3390/jcm10174013

Schneider, Matthias, Niklas Schäfer, Christian Bode, Lars Eichhorn, Frank A. Giordano, Erdem Güresir, Muriel Heimann, Yon-Dschun Ko, Jennifer Landsberg, Felix Lehmann, and et al. 2021. "The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival" Journal of Clinical Medicine 10, no. 17: 4013. https://doi.org/10.3390/jcm10174013

Schneider, M., Schäfer, N., Bode, C., Eichhorn, L., Giordano, F. A., Güresir, E., Heimann, M., Ko, Y.-D., Landsberg, J., Lehmann, F., Radbruch, A., Schaub, C., Schwab, K. S., Weller, J., Herrlinger, U., Vatter, H., & Schuss, P. (2021). The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival. Journal of Clinical Medicine, 10(17), 4013. https://doi.org/10.3390/jcm10174013